Men and women: Cancer risk from obesity differs: A new study, co-funded by World Cancer Research Fund (WCRF), Cancer Research UK and Diabetes UK, reveals...
Meet the finalist | Dr Jonathan Evans RSM Coloproctology Section Presentation title: The Nrf2 inhibitor Brusatol is a potent antitumour agent, and enhances irinotecan cytotoxicity, in an orthotopic...
Colorectal cancer is a general term applied to malignant tumours occurring anywhere within the colon (large bowel or large intestine). This includes the rectum which...